Next generation sequencing companies provide technologies and services for analysing DNA and RNA at high throughput. Also known as NGS, these approaches support genomics research, clinical testing, drug development and the study of genetic variation and gene expression.
This category includes companies working on:
Browse 71 UK next generation sequencing companies below.
High molecular weight DNA extraction kits for long-read sequencing
RevoluGen is a developer of molecular tools for isolating long, high-purity DNA from cells for sequencing and genomic analysis. The company's patented nucleic acid isolation technology extracts and size-selects long DNA fragments suited to long-read sequencing, genome assembly and long-range PCR, and is available as…
NGS liquid biopsy testing for cancer in dogs and cats
CanCan Diagnostics is a veterinary biotechnology company developing next-generation sequencing tests for cancer detection and monitoring in companion animals. Its K9 LiquiDx liquid biopsy analyses tumour-associated mutations in circulating cell-free DNA from canine blood samples. The company also offers tissue-based…
Specialist molecular pathology, histopathology and spatial biology CRO
Propath (UK) is a contract research organisation providing GLP and GCP-compliant molecular pathology, histopathology, and spatial biology services to the global biopharmaceutical industry. Operating from a dedicated 12,000 square foot facility in Hereford, the company delivers spatial transcriptomics, highly…
Federated genomic data platform for secure biomedical research
Lifebit is a London-based software company providing a federated Trusted Research Environment for large-scale health and genomic data analysis. Its platform enables pharmaceutical companies, health systems, and research organisations to access, harmonise, and analyse distributed clinico-genomic datasets securely,…
Rapid genomic diagnostic device for sepsis and bacterial infections
GenomeKey is a biotechnology company developing an in vitro diagnostic device that uses whole genome sequencing and machine learning to identify bacteria and their antimicrobial resistance profiles directly from patient blood within hours. The device targets sepsis, where current culture-based diagnostics take 24 to…
Applied genetics and genomics services and distribution for DNA testing
Biosecure ID is a contract research organisation providing professional services and integrated workflow solutions for applied genetics and genomics testing. The company supports academic, clinical, and forensic laboratories with workflow validation, implementation, and turnkey project delivery across NGS, STR…
Rapid airborne DNA sequencing service for pathogen detection and biosecurity
Agnos Biosciences is a deep tech company commercialising AirSeq, a rapid DNA air sequencing technology for the detection and quantification of airborne biological material. AirSeq combines novel molecular biology, DNA sequencing and bespoke computational analysis to simultaneously identify thousands of species,…
BBSRC-funded genomics and bioinformatics research institute
The Earlham Institute is a BBSRC-funded life science research institute based at Norwich Research Park, specialising in genomics, bioinformatics, single-cell research and engineering biology. Its research applies computational science and biotechnology to decode living systems across plant science, microbiology,…
Multiplex PCR and NGS diagnostics for cancer and infection
GeneFirst is a molecular diagnostics company developing multiplex PCR assays and next-generation sequencing technologies for cancer screening, precision oncology and infectious disease testing. Its Papilloplex assays detect high-risk human papillomavirus DNA or E6/E7 mRNA. The XCeloSeq platform provides library…
Reagents that stabilise and fix RNA, DNA and tissue samples
RNAssist is a reagents company developing patented stabilisation and fixation products for biological samples. Its formulations, based on deep eutectic solvents, preserve RNA, DNA, proteins and cell structure at the point of collection and are compatible with downstream methods such as single-cell sequencing and…
Global leader in next-generation sequencing and genomic analysis
Illumina is a US-headquartered life science company and the dominant provider of next-generation sequencing platforms and array-based genotyping tools. Its UK operations are based at Granta Park in Cambridge, serving as its primary European research and commercial hub. Illumina's technologies underpin applications in…